Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

Vaccine trial at VIDO-InterVac underway

VIDO InterVac’s COVID-19 vaccine trial is underway. Global News Morning talks to the facility’s director Dr. Volker Gerdts about the first phase of the trial and potential benefits of the Saskatchewan-made vaccine.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article